Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Montefiore Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Thomas Jefferson University
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
Aprea Therapeutics
Fred Hutchinson Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Syros Pharmaceuticals
Ensoma
Vanderbilt-Ingram Cancer Center
Stanford University
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Weill Medical College of Cornell University
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Rutgers, The State University of New Jersey
Northside Hospital, Inc.
Celgene
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Medical College of Wisconsin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins